Schrödinger and Bayer have announced a five-year technology allia...
Lannett Company, Inc. has commenced marketing Venlafaxine Extended Rel...
ProBioGen AG has signed a commercial license agreement with Roche...
genOway, a leading company in the development of genetically modified ...
UK based MiNA Therapeutics has announced the initiation of a research ...
Velabs Therapeutics, a biotech company focused on the rapid screening ...
Polyganics, a medical technology company developing, manufacturing and...
Immunotherapy is forecast to become the oncology treatment of choice b...
Merck, known as MSD outside the United States and Canada, has announce...
Molina Healthcare has entered into a definitive agreement to acquire a...
Ebb Therapeutics is on a mission to make an impact in both the pr...
Biostage, a bioengineering company developing next-generation esophage...
Researchers from the National Institutes of Health’s National In...
Universal Transport Medium (UTM) ® is an FDA-cleared collecti...
Eli Lilly and Company has announced the opening of the LIBRETTO-531 cl...
The Janssen Pharmaceutical Companies of Johnson & Johnson announce...
The U.S. Food and Drug Administration has approved two applications fo...
AstraZeneca and MSD have announced that Lynparza (olaparib) ...